logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Life Science
Filter

Life Science

Categories

Sectors

Locations

Exchange

Thank You for a Remarkable and Transformational Year

Jan 2, 2020

中国批准国产13价肺炎疫苗上市

China approves home-grown vaccines, offering alternative to global drugmakers’ products

Dec 31, 2019

Life Science

医疗保健精选——EyeGate Pharma申请发行50万股股票,制药商提高美国药价

Healthcare Roundup – EyeGate Pharma files for 500K-share stock offering, Drugmakers to hike U.S. prices

Dec 31, 2019

Life Science

医疗保健精选——XBiotech完成向强生出售bermekimab,Acceleron Pharma与Fulcrum Therapeutics合作

Healthcare Roundup – XBiotech says bermekimab sale to J&J closes, Acceleron Pharma teams up with Fulcrum Therapeutics

Dec 30, 2019

Life Science

GTEC Extends Agreement to Facilitate Acquisition of Cannabis Genetics and Provides Updates on Other Corporate Matters

Dec 24, 2019

Life Science

医疗保健精选——赛诺菲拟收购Synthorx,再生元的埃博拉病毒治疗药获孤儿药资质

Healthcare – Sanofi begins tender offer for Synthorx buy-out, Regeneron’s Ebola treatment gets orphan status

Dec 23, 2019

Life Science

Avalon GloboCare Partners with China (Nanjing) Cell Valley to Advance Cellular Medicines

Dec 20, 2019

Life Science

医疗保健精选——强生收购Talead Biomedical,吉利德的Vosevi在中国获批

Healthcare Roundup – J&J acquires Taris Biomedical, Gilead’s Vosevi OK’d in China

Dec 20, 2019

Life Science

Aleafia Health Inc. (TSX ALEF)

Aleafia Health Provides Update Regarding Product Shipment

Dec 20, 2019

Life Science

WELL Health Receives Conditional Approval to Graduate to the TSX

Dec 20, 2019

Life Science

医疗保健精选——安进提交美国Rituxan生物仿制药的申请,吉利德提交美国的filgotinib的申请

Healthcare Roundup – Amgen files U.S. application for Rituxan biosimilar, Gilead files U.S. application for filgotinib

Dec 19, 2019

Life Science

复星凯特

China’s Fosun, US’s Kite to Start Making Pioneering Lymphoma Drug in Shanghai

Dec 19, 2019

Life Science

医疗保健 白宫发布计划,Illumina提高对Pacific Bio的报价

Healthcare Roundup – White House releases plan, Illumina to pay up to $34M to extend offer for Pacific Bio

Dec 18, 2019

Life Science

山东方坦思宣布与杨森制药

Shandong Fontacea Announces License Agreement with Janssen to Develop and Commercialize Anti-IL17A Monoclonal Antibody

Dec 18, 2019

Life Science

医疗保健精选 – 默克收购Vaki,CytoDyn授予leronlimab许可授权

Healthcare Roundup – Merck adds to aquaculture portfolio, CytoDyn out-licenses U.S. rights to leronlimab for HIV

Dec 17, 2019

Life Science

Cellestia Biotech AG融资

Cellestia Biotech AG successfully closes Series B financing round, raising a total of CHF 20 million

Dec 17, 2019

Life Science

药捷安康

TransThera Biosciences Announces IND Approval from FDA for Clinical Studies of TT-00920 to Treat Chronic Heart Failure

Dec 17, 2019

Life Science

医疗保健精选——美国批准罗氏与Spark Therapeutics合并,FDA肿瘤药物咨询委员会讨论阿斯利康的Lynparza

Healthcare Roundup – U.S. approves Roche-Spark merger, Ad Com Tuesday for AstraZeneca’s Lynparza for maintenance of pancreatic cancer

Dec 16, 2019

Life Science

  • ‹‹ Previous
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada